DK331479A - Fremgangsmaade til fremstilling af cycliske diamider - Google Patents

Fremgangsmaade til fremstilling af cycliske diamider

Info

Publication number
DK331479A
DK331479A DK331479A DK331479A DK331479A DK 331479 A DK331479 A DK 331479A DK 331479 A DK331479 A DK 331479A DK 331479 A DK331479 A DK 331479A DK 331479 A DK331479 A DK 331479A
Authority
DK
Denmark
Prior art keywords
diamids
manufacturing cyclic
cyclic
manufacturing
cyclic diamids
Prior art date
Application number
DK331479A
Other languages
English (en)
Inventor
G Wootton
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of DK331479A publication Critical patent/DK331479A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
DK331479A 1978-08-08 1979-08-07 Fremgangsmaade til fremstilling af cycliske diamider DK331479A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7832678 1978-08-08

Publications (1)

Publication Number Publication Date
DK331479A true DK331479A (da) 1980-02-09

Family

ID=10498937

Family Applications (1)

Application Number Title Priority Date Filing Date
DK331479A DK331479A (da) 1978-08-08 1979-08-07 Fremgangsmaade til fremstilling af cycliske diamider

Country Status (8)

Country Link
EP (1) EP0008186A1 (da)
JP (1) JPS5524198A (da)
AU (1) AU4940579A (da)
CA (1) CA1127641A (da)
DK (1) DK331479A (da)
ES (1) ES483253A1 (da)
IL (1) IL57933A0 (da)
ZA (1) ZA793937B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8427735D0 (en) * 1984-11-02 1984-12-12 Fujisawa Pharmaceutical Co Piperazine compound
DE3830096A1 (de) * 1988-09-03 1990-03-15 Hoechst Ag Piperazindione mit psychotroper wirkung
AR030817A1 (es) * 2000-10-02 2003-09-03 Novartis Ag Derivados de diazacicloalcanodiona
US7053085B2 (en) * 2003-03-26 2006-05-30 Merck & Co. Inc. EP4 receptor agonist, compositions and methods thereof
WO2006014207A1 (en) * 2004-07-02 2006-02-09 Allergan, Inc. Prostaglandin analogs
WO2023196527A2 (en) * 2022-04-08 2023-10-12 SunVax mRNA Therapeutics Inc. Ionizable lipid compounds and lipid nanoparticle compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1598662A (en) * 1976-12-18 1981-09-23 Beecham Group Ltd 10,12-diazoprostaglandins

Also Published As

Publication number Publication date
ES483253A1 (es) 1980-09-01
EP0008186A1 (en) 1980-02-20
ZA793937B (en) 1980-07-30
IL57933A0 (en) 1979-11-30
JPS5524198A (en) 1980-02-21
AU4940579A (en) 1980-02-14
CA1127641A (en) 1982-07-13

Similar Documents

Publication Publication Date Title
DK161048C (da) Fremgangsmaade til fremstilling af humant interferon
DK428179A (da) Fremgangsmaade til fremstilling af metaboliter
DK144779A (da) Fremgangsmaade til fremstilling af quinazoliner
DK25579A (da) Fremgangsmaade til fremstilling af interferon
DK150623C (da) Fremgangsmaade til fremstilling af fiskemel
DK421477A (da) Fremgangsmaade til fremstilling af vacciner
DK156253C (da) Fremgangsmaade til fremstilling af pyruvatoxidase
DK366778A (da) Fremgangsmaade til taelling af bakterier
DK155084C (da) Fremgangsmaade til fremstilling af meta-aryloxy-benzaldehyder
DK150984C (da) Fremgangsmaade til kontinuerlig fremstilling af azopigmenter
DK149446C (da) Fremgangsmaade til fremstilling af acylcyanider
DK147436C (da) Fremgangsmaade til fremstilling af acylcyanider
DK152752C (da) Fremgangsmaade til fremstilling af l-sulpirid
DK87079A (da) Fremgangsmaade til fremstilling af dialkylphospohorchloridothioter
DK331479A (da) Fremgangsmaade til fremstilling af cycliske diamider
DK229479A (da) Fremgangsmaade til fremstilling af forbindelser af muramylpeptidtypen
DK155042C (da) Fremgangsmaade til fremstilling af cement
DK149447C (da) Fremgangsmaade til fremstilling af acylcyanider
DK258177A (da) Fremgangsmade til fremstilling af methicillinalkylaminoalkylestere
DK36379A (da) Fremgangsmaade til fremstilling af n-ethylethylendiamin
DK143107C (da) Fremgangsmaade til fremstilling af 2-isopropylaminopyrimidin
DK152295C (da) Fremgangsmaade til filtrering af oel
DK588677A (da) Fremgangsmaade til fremstilling af azopigmenter
DK147420C (da) Fremgangsmaade til fremstilling af acylcyanider
DK152112C (da) Fremgangsmaade til fremstilling af cement

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment